What Therapeutic Guidelines does

Therapeutic Guidelines Limited (TGL) is an independent Australian not-for-profit organisation founded in 1978, headquartered in North Melbourne, Victoria. It develops and publishes point-of-care clinical guidelines for Australian healthcare practitioners, offering 22 comprehensive guidelines covering approximately 2,500 conditions with treatment advice, supporting resources, and calculators. Its core product portfolio spans independently developed Therapeutic Guidelines content, the Australian Prescriber peer-reviewed journal and fortnightly podcast (licensed from the Australian Government Department of Health, Disability and Ageing), and three clinical reference products licensed through Advanced Pharmacy Australia — Australian Injectable Drugs Handbook (AIDH), ObesiD, and Don't Rush to Crush. The organisation is currently transitioning to a living guidelines approach optimised for point-of-care delivery, with the June 2026 release covering Respiratory and Sexual and Reproductive Health areas.

TGL distributes its products through a digital-first subscription model — both institutional (hospitals, healthcare networks, universities) and individual practitioner subscriptions — managed via its web portal and mobile app. Revenue is supplemented by copyright fees from commercial publishers and physical book sales for select titles (Ulcer and Wound Management; Palliative Care v5, 2024). The Australian Prescriber journal is offered free to all healthcare professionals, with over 100,000 subscribers. A Partnership Program, funded by the Therapeutic Guidelines Foundation since 2016, provides free subscriptions to healthcare workers and institutions in low- and lower-middle-income countries across the Pacific, South-East Asia, and Australian overseas aid priority regions. The offline-first Guideline Host mobile app has been deployed in Fiji, Solomon Islands, and Vanuatu since 2018, achieving over 10,000 downloads, and has supported local guideline development in multiple countries including assisting PNG's National Department of Health with its first national antimicrobial guidelines.

TGL recently expanded its mandate when it was appointed by the Australian Department of Health, Disability and Ageing as the new digital health care publisher of the Remote Primary Health Care Manuals (RPHC Manuals). The organisation maintains strict editorial independence from pharmaceutical industry influence, with explicit governance policies prohibiting use of its content for commercial promotional purposes. The platform uses Microsoft Entra ID B2C for subscription authentication. No public APIs, developer tools, or AI features are documented.

Name

Therapeutic Guidelines

Legal name

Therapeutic Guidelines Limited

Website

https://tg.org.au

Company type

Private

Founded year

1978

Operating status

Operating

Headcount range

11–50 employees

Short description

Therapeutic Guidelines Limited is an Australian independent not-for-profit founded in 1978 that publishes 22 point-of-care clinical guidelines covering approximately 2,500 conditions, serving Australian healthcare practitioners and institutions via subscription, with free access extended globally through a Partnership Program.

Ownership category

akta.pro rank

Product category

Clinical Decision Support Software

SIC

Services-Misc Health & Allied Services, Nec (8090), Services-Prepackaged Software (7372)

akta.pro primary industry

Medical & Clinical Reference (Physicians, Nursing, Allied Health) (EDAGAGAA)

akta.pro secondary industry

Medication Therapy Management (MTM) & Clinical Pharmacy Services Tools (HLACAKAH)

Keywords

• Clinical decision support
• Evidence-based guidelines
• Medical reference publishing
• Drug information resources
• Clinical reference platform

Headquarters

HQ city

Melbourne

HQ country

Australia

HQ region

Oceania

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Others

Revenue model

1. Subscription revenue (institutional): Therapeutic Guidelines generates revenue primarily through institutional subscriptions — hospitals, healthcare networks, universities, and other organisations pay for access to the platform for their staff and students. Subscriptions are managed through the website portal.
2. Subscription revenue (individual): Individual healthcare practitioners (GPs, pharmacists, specialists) subscribe on a single-user basis for direct access to Therapeutic Guidelines.
3. Book sales: Limited physical book sales — currently Ulcer and Wound Management guidelines and Palliative Care guidelines (version 5, 2024) are available for individual purchase via a book order form. Most guidelines have transitioned to digital-only publishing.
4. Copyright fees from commercial publishers: Therapeutic Guidelines Limited and Advanced Pharmacy Australia reserve the right to charge a copyright fee to commercial publishers and other commercial enterprises for reproduction of content.
5. Partnership Program funding: Since 2016, the Partnership Program is funded by the Therapeutic Guidelines Foundation. Free subscriptions are provided to individuals and institutions in resource-limited settings globally.
6. Australian Prescriber (free): Australian Prescriber is a free, independent peer-reviewed journal. Revenue is not generated directly from this product; it serves as a broader engagement and awareness channel for the organisation's mission.

Go-to-market motion1 record

Distribution channels5 records

Marketing channels6 records

Core offering

Therapeutic Guidelines publishes point-of-care clinical decision support resources, anchored by the flagship Therapeutic Guidelines suite of 22 comprehensive clinical guidelines covering approximately 2,500 conditions with treatment advice, supporting resources and calculators. The portfolio also includes the Australian Prescriber peer-reviewed journal and fortnightly podcast, plus licensed pharmaceutical reference resources (Australian Injectable Drugs Handbook, ObesiD, Don't Rush to Crush), distributed primarily through institutional and individual subscriptions to its digital platform and mobile app.

Product overview

Therapeutic Guidelines Limited operates a platform of clinical decision support resources for Australian healthcare practitioners. The core product is Therapeutic Guidelines, a comprehensive digital resource covering 22 clinical areas with treatment advice for 2,500 conditions. The portfolio also includes licensed publications developed with Advanced Pharmacy Australia (Australian Injectable Drugs Handbook, ObesiD, Don't Rush to Crush) and the independently published Australian Prescriber journal with its fortnightly podcast. The company also publishes the Remote Primary Health Care Manuals and offers the Guideline Host offline mobile app for international partners. Most guidelines are digital-only, with select titles (Palliative Care, Ulcer and Wound Management) still available in book format. The company provides a free Partnership Program for resource-limited international settings.

Differentiator

Problem solved

Functional benefit

Brands

• Guideline Host App: An offline-first mobile application implemented in partnership with countries to host locally developed or endorsed guidelines, essential medicines lists and other resources.

Products and services

• Therapeutic Guidelines (eTG complete) Leading point-of-care clinical resource for Australian health practitioners, providing comprehensive treatment advice across 22 clinical guidelines covering approximately 2,500 conditions, along with supporting resources and calculators; sold via institutional and individual subscriptions.
• Australian Prescriber Free, independent peer-reviewed journal and fortnightly podcast providing critical commentary on drugs and therapeutics for health professionals, with CPD-accredited articles for RACGP members; trusted by over 100,000 healthcare professionals.
• ObesiD Australia's first clinical resource dedicated to dosing in patients with obesity, providing dosing guidance for healthcare practitioners treating patients with obesity; published in partnership with Advanced Pharmacy Australia.
• Don't Rush to Crush Australia's trusted guide to safely administering oral medicines to people with enteral feeding tubes or swallowing difficulties; published in partnership with Advanced Pharmacy Australia.
• Australian Injectable Drugs Handbook (AIDH) 10th Edition Australia's essential guide to safely administering injectable medicines, currently in its 10th edition; licensed from Advanced Pharmacy Australia and sold to Australian healthcare practitioners via the platform.
• Antibiotic Prescribing Summary Free downloadable summary table of antibiotic prescribing in primary care, summarising information in Therapeutic Guidelines about the management of common conditions in primary care; available without subscription.
• Palliative Care Guidelines (Book, Version 5) Evidence-based palliative care guidelines covering individualised assessment and management of patients with life-limiting illness, available as a physical book (Version 5, 2024) for individual purchase.
• Ulcer and Wound Management Guidelines Guidelines covering ulcer and wound management available for purchase in physical book format via downloadable book order form, representing one of the few remaining print publications.
• Remote Primary Health Care Manuals (RPHC Manuals) Digital health care guidelines for remote primary health care settings, newly acquired publishing responsibility from the Australian Government Department of Health, Disability and Ageing.
• Guideline Host Mobile App Offline-first mobile application hosting locally developed or endorsed guidelines, essential medicines lists, and other resources for countries with unreliable internet access; deployed in partnership with national health ministries.

Quantifiable outcome

• Over 100,000 healthcare professionals subscribe to Australian Prescriber
• +3 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

Feature6 records

Partnerships

Seven partnerships are on record, tiered core and supporting.

• Fiji Ministry of Health (Guideline Host program)coreStrategic or Co-development Partner · 1 January 2018Since 2018, Therapeutic Guidelines has implemented the Guideline Host offline-first mobile app in Fiji in partnership with the country's health ministry. The app hosts locally developed or endorsed guidelines, essential medicines lists and other resources for Fiji's health practitioners. The app has been downloaded by over 10,000 individuals in Fiji.
• Solomon Islands Ministry of Health (Guideline Host program)coreStrategic or Co-development Partner · 1 January 2018Since 2018, the Guideline Host app has been implemented in Solomon Islands in partnership with the country's health ministry. The app provides offline access to locally relevant guidelines and essential medicines lists for health practitioners in Solomon Islands.
• Vanuatu Ministry of Health (Guideline Host program)coreStrategic or Co-development Partner · 1 January 2018Since 2018, the Guideline Host app has been implemented in Vanuatu in partnership with the country's health ministry. The app has been downloaded by over 10,000 individuals across Fiji, Solomon Islands and Vanuatu combined.
• Department of Health, Disability and Ageing (Australian Government)coreStrategic or Co-development PartnerTherapeutic Guidelines Limited (TGL) was appointed by the Department of Health, Disability and Ageing as the new digital health care publisher of the Remote Primary Health Care Manuals (RPHC Manuals). This appointment represents a significant expansion of TGL's publishing responsibilities within the Australian healthcare ecosystem.
• Burnet InstitutesupportingStrategic or Co-development PartnerTherapeutic Guidelines collaborated with the Burnet Institute on a large project to assist the PNG National Department of Health to write the first edition of their national antimicrobial guidelines. This project was part of TGL's broader Partnership Program supporting guideline development in low-resource settings.
• International Society of Drug Bulletins (ISDB)supportingOthersTherapeutic Guidelines Limited is a member of the International Society of Drug Bulletins (ISDB), a network of bulletins and journals on drugs and therapeutics that are independent of pharmaceutical industry influence. ISIUM (International Society of Drug Bulletins Users and Manufacturers) meetings are referenced as part of the Partnership Program activities.
• Fiji, Kiribati and Tuvalu Ministries of HealthsupportingStrategic or Co-development PartnerIn recent years, Therapeutic Guidelines has assisted the Ministries of Health in Fiji, Kiribati and Tuvalu to revise their antibiotic guidelines and Fiji to update its respiratory guidelines. This support was provided through the Partnership Program and included permission to adapt Therapeutic Guidelines content and linking guideline writers with relevant Australian experts.

Scale indicators6 records

Recent moves6 records

Expansion highlights10 records

Direct peers

• epocrates: epocrates is a widely used mobile-first point-of-care drug and clinical reference for prescribers. It overlaps with Therapeutic Guidelines' mobile/app-based clinical reference use case, particularly for individual practitioners seeking quick prescribing guidance.
• Medscape: Medscape (WebMD) provides free point-of-care clinical reference content, drug information and CME for healthcare professionals. It is comparable to Therapeutic Guidelines' free Australian Prescriber journal/podcast as a clinician engagement and reference channel.
• Lexicomp: Lexicomp (Wolters Kluwer) provides point-of-care drug information and clinical decision support, including dosing, interactions and administration guidance. It is directly comparable to the drug-handbook elements of the Therapeutic Guidelines portfolio (e.g. AIDH, Don't Rush to Crush).
• Sanford Guide: Sanford Guide is a long-standing antimicrobial therapy reference used by clinicians globally. It is a focused direct peer for Therapeutic Guidelines' antibiotic prescribing content, which has historically been a flagship product since the 1978 founding.
• Australian Medicines Handbook (AMH): AMH is an independent Australian drug reference used by GPs, pharmacists and students. It is the closest direct competitor to Therapeutic Guidelines in the Australian market, sharing a similar independent, not-for-profit positioning and overlapping institutional customer base.
• DynaMed: DynaMed (EBSCO) is a subscription point-of-care clinical reference covering thousands of conditions with treatment recommendations. It competes with Therapeutic Guidelines for hospital and individual clinician subscriptions in the evidence-based clinical decision support category.
• BMJ Best Practice: BMJ Best Practice is BMJ's point-of-care clinical decision support product providing evidence-based guidance across conditions. It targets the same institutional and individual clinician segments as Therapeutic Guidelines and competes for global clinical reference budgets.
• MIMS Australia: MIMS is the Australian edition of a long-established drug information reference used by Australian prescribers. It directly overlaps with Therapeutic Guidelines in drug monographs and decision support, competing for institutional and individual subscriptions.
• UpToDate: Wolters Kluwer's UpToDate is the leading global point-of-care clinical decision support resource for physicians. It is directly comparable to Therapeutic Guidelines as a subscription-based, evidence-based clinical reference used at the point of care, though it is significantly broader in scope and geographic reach.

Broad incumbents

• ClinicalKey: ClinicalKey is Elsevier's broad clinical reference platform combining books, journals, guidelines and decision support. It is a broader incumbent competitor to Therapeutic Guidelines, offering overlapping clinical content as part of a much wider enterprise information portfolio rather than a focused guidelines product.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeopen.spotify.com/show/5bepycNoe1Leh0ktZy5AZe
• Xx.com/TGLGuidelines
• Facebookfacebook.com/TherapeuticGuidelinesPartnershipProgram

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Therapeutic Guidelines